Endocrinol Metab.  2018 Jun;33(2):195-201. 10.3803/EnM.2018.33.2.195.

Triennial Report of Endocrinology and Metabolism, 2015 to 2017

• Rhee EJ
• Jang HY
• Lee WY

• KMID: 2420486
• DOI: http://doi.org/10.3803/EnM.2018.33.2.195

Abstract

No abstract available.

MeSH Terms

Endocrinology*
Metabolism*

Reference

1. Lee WY. Endocrinology and Metabolism is indexed in the emerging sources citation index. Endocrinol Metab (Seoul). 2017; 32:350–352. PMID: 28956364.

2. Trimboli P, Giovanella L. Procalcitonin as marker of recurrent medullary thyroid carcinoma: a systematic review and meta-analysis. Endocrinol Metab (Seoul). 2018; 22:204–210.

3. Hong N, Lee Y, Tsujita K, Gonzalez JA, Kramer CM, Kovarnik T, et al. Comparison of the effects of ezetimibe-statin combination therapy on major adverse cardiovascular events in patients with and without diabetes: a meta-analysis. Endocrinol Metab (Seoul). 2018; 22:219–227.

4. Hyun KR, Kang S, Lee S. Cost-of-illness trends associated with thyroid disease in Korea. Endocrinol Metab (Seoul). 2014; 29:257–269. PMID: 25309784.

5. Sohn SY, Jang HW, Cho YY, Kim SW, Chung JH. Economic evaluation of recombinant human thyroid stimulating hormone stimulation vs. thyroid hormone withdrawal prior to radioiodine ablation for thyroid cancer: the Korean perspective. Endocrinol Metab (Seoul). 2015; 30:531–542. PMID: 26394733.

6. International Committee of Medical Journal Editors. Recommendations [Internet]. ICMJE: c2018. cited 2018 Jun 7. Available from: http://icmje.org/recommendations.